1 / 11

Nuclear Medicine/ Radiopharmaceuticals Market is Set to Boom by 2022

Nuclear Medicine/ Radiopharmaceuticals Market is expected to garner $8,207.5 million by 2022. The market is currently in its growth stage driven by increasing number of cancer cases and rising awareness about nuclear medicine.

Abhi711
Download Presentation

Nuclear Medicine/ Radiopharmaceuticals Market is Set to Boom by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nuclear Medicine/Radiopharmaceuticals Market Opportunity Analysis and Industry Forecast, 2016-2023 Global Opportunity Analysis and Industry Forecast, 2014-2022

  2. Introductionof Nuclear Medicine/Radiopharmaceuticals Market Nuclear Medicine/RadiopharmaceuticalsMarket is expected to garner $8,207.5 million by 2022. The global radiopharmaceuticals market is poised to grow at a significant pace, owing to growing demand for non-invasive techniques, availability of effective cancer treatment, and ability to observe the functioning of the organ from outside the body. Furthermore, increasing incidence of cancer & cardiovascular aliments, growing demand for alpha radio immunotherapy-based targeted cancer treatment, mounting call for nuclear imaging techniques, and advancements in radiotracers are expected to open new avenues in the radiopharmaceuticals market. Factors that are expected to drive the use of radiopharmaceuticals include changing lifestyle, elevated levels of stress, and ability to identify various diseases sooner than other diagnostic tests. However, factors such as supply volatility & logistical challenges, stringent regulatory vigil, and competition from conventional diagnostic procedures are anticipated to impede the market growth.

  3. Introductionof Nuclear Medicine/Radiopharmaceuticals Market Scopeof theReport KeyBenefits KeyAudiences

  4. Key Benefits • Therapeutics segment is projected to be the fastest growing segment in the radiopharmaceuticals market, registering a CAGR of 16.9% from 2016 to 2022. • SPECT modality segment is expected to dominate the radiopharmaceuticals market in 2015 and expected to retain its position throughout the study period. • Thyroid application segment is expected to exhibit double-digit CAGR of 11%. • Oncology application segment is expected to continue to lead the radiopharmaceuticals market, accounting for close to 60% share by 2022. • Asia-Pacific is projected to be the fastest growing radiopharmaceuticals market, registering a CAGR of 8.4%.

  5. Table of Content (TOC) Chapter: 1 Introduction Chapter: 2 Executive Summary Chapter: 3 Market Overview Chapter: 4 World Radiopharmaceuticals Market, By Type, 2014-2022 Chapter: 5 World Radiopharmaceuticals Market, By Modality, 2014-2022 Chapter: 6 World Radiopharmaceuticals Market, By Application, 2014-2022 Chapter: 7 World Radiopharmaceuticals Market, By End-user, 2014-2022 Chapter: 8 World Radiopharmaceuticals Market, By Geography, 2014-2022 Chapter: 9 Company Profiles

  6. Segments Nuclear Medicine/Radiopharmaceuticals Market

  7. Segments Nuclear Medicine/Radiopharmaceuticals Market

  8. Segments Nuclear Medicine/Radiopharmaceuticals Market

  9. Segments Nuclear Medicine/Radiopharmaceuticals Market

  10. Company Profiles Nuclear Medicine/Radiopharmaceuticals Market Mallinckrodt plc. General Electric Co. Medtronic, plc. (Covidien, acquired by Medtronic) Bayer AG Cardinal Health, Inc. Lantheus Medical Imaging, Inc.

  11. Thank You Nuclear Medicine/Radiopharmaceuticals Market ThankYou! For MoreDetails Do Enquiry https://www.alliedmarketresearch.com/nuclear-medicine-radiopharmaceuticals-market Follow UsOn

More Related